Potential Interactions Between Contra Caps, Antihistamines, and Montelukast

Introduction to Combination Therapy

The American Academy of Allergy, Asthma, and Immunology suggests that there are no significant drug interactions of clinical concern between common pain relievers and antihistamines or montelukast, making this combination generally safe for most patients 1

The British Association of Dermatologists notes that contra caps typically contain analgesics like ibuprofen or acetaminophen, which have no documented significant interactions with antihistamines 2
Second-generation antihistamines have minimal sedative effects and do not significantly interact with common pain medications, according to the British Association of Dermatologists 2
First-generation antihistamines may cause additive sedation when combined with medications that have CNS depressant effects, but this is not a concern with typical analgesic doses, as stated by the British Association of Dermatologists 2

For patients with allergic rhinitis and asthma, montelukast provides the benefit of treating both conditions simultaneously, making it a valuable option when combined with antihistamines, as recommended by the European Academy of Allergy and Clinical Immunology 3
The combination of montelukast with antihistamines has been shown to provide better symptom control for allergic rhinitis than either therapy alone, according to the European Academy of Allergy and Clinical Immunology 3

The American Academy of Allergy, Asthma, and Immunology recommends that when performing challenge testing for exercise-induced bronchoconstriction, antihistamines should be withheld for 72 hours and leukotriene receptor antagonists for 4 days 1

In patients with allergic rhinitis and concomitant asthma, montelukast plus antihistamine therapy provides greater efficacy than either medication alone, as found by the European Rhinologic Society 4, 5

Antileukotrienes like montelukast may be taken in addition to H1 antihistamines for poorly controlled urticaria, though there is limited evidence for their use as monotherapy, according to the British Association of Dermatologists 2